Healthcare Reform
Our work in Healthcare Reform
-
A Comprehensive Strategy for Primary Care Payment Reform in Medicare
The CPC+ACO model should be evaluated now as a possible path for smaller, independent physician practices.
Categorized in -
Are Settlements in Patent Litigation Collusive? Evidence from Paragraph IV Challenges
Estimating the use of “pay-for-delay” settlements in patent litigation—in which a branded manufacturer and generic entrant settle a Paragraph IV patent challenge and agree to forestall entry—this study found that such challenges increase generic entry, lower drug prices and increase quantity, while settlements effectively reverse the effect.
Categorized in -
Self-Insuring against Liability Risk: Evidence from Physician Home Values in States with Unlimited Homestead Exemptions
This study considered physicians’ investments in self-insurance by exploring how they respond to policies that allow them to lower the financial cost of malpractice liability, and found that physicians take financially costly decisions to protect themselves from uninsured malpractice risk, implying more generally that individuals self-insure against liability risk when insurance markets are incomplete.
Categorized in -
Schaeffer Center Experts Quoted in Multiple New York Times articles this week
Three journalists with The New York Times reached out to Schaeffer Center experts for insight into pressing health policy issues this week.
Categorized in -
DC Health Policy Forum Focuses on Shaping Nation’s Healthcare System
The forum gave students the opportunity to delve into the intricacies of health policy.
-
House Calls Program for Ailing Seniors Saves Healthcare Dollars, Study Finds
The program became more efficient as it reduced health care spending and hospitalization rates over the course of a few years.
Categorized in -
Doctors Who Spend More on Patients Face Lower Malpractice Claim Risk
Physicians who spend more money conducting tests and procedures for patients are less likely to be sued.
-
The Effect of Federal Research Funding on Formation of University-Firm Biopharmaceutical Alliances
In this paper, researchers evaluated the effects of National Institutes of Health (NIH) research funding on US universities’ alliance formation, and estimated that, on average, producing one additional university-firm alliance requires a sustained increase of $294 million in universities’ total NIH research funding over the preceding five-year period.
Categorized in -
Low-Income Workers May Get Run Over by ACA’s Cadillac Tax
An analysis by Trish and Herring finds that the Cadillac tax actually increases inequity across workers of different income levels rather than reducing it.
Categorized in -
University R&D Funding Strategies in a Changing Federal Funding Environment
This paper evaluated how changes in National Institutes of Health funding levels affected US universities’ total biomedical R&D efforts over a period of dramatic change in the federal funding environment.
Categorized in